CNN (score 2): correct conserved catalytic function, already carried by GOA for this accession as branched-chain amino acid catabolism and branched-chain transaminase activity.
Target: A0A9L0TSN4, Equus caballus. The exact source is the frozen ProtNLM API response dated 2026-09-08, retained in projects/PROTNLM_EVALUATION/mammal-benchmark/predictions.jsonl.gz.
Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine
CNN. Human mitochondrial BCAT2 structural and kinetic work establishes transamination of branched-chain substrates (PMID:17050531). The horse protein aligns across the full human enzyme and preserves the PLP Schiff-base lysine, the CXXC motif and the mapped substrate-contact residues. The extra 59-residue N-terminal segment does not remove that catalytic domain. GOA already annotates this accession to branched-chain amino acid catabolic process (GO:0009083) and branched-chain-amino-acid:2-oxoglutarate transaminase activity (GO:0004084), so the claim is not novel.
CNN. The experimentally characterized human enzyme has the substrate spectrum given in the prediction. Its human UniProt functional statement is grounded in biochemical papers, including PMID:17050531 and PMID:25653144; mapped contacts and broad sequence conservation support transfer to this horse enzyme. Leucine, isoleucine and valine are the three proteinogenic branched-chain amino acids, so naming them is equivalent to the annotated branched-chain amino acid catabolic process and branched-chain transaminase activity rather than a more specific novel claim.
The statement is a plausible conserved mammalian enzyme function, not an equine-specific experimental observation. The selected model has a long N-terminal extension; this analysis does not certify mitochondrial targeting. The narrative restates, at substrate level, the branched-chain amino acid catabolism and transaminase activity that GOA already carries for this accession, which is the only horse BCAT2 product reviewed here; training membership is unknown.
The reproducible paired sequence comparison records residue-level findings and sequence hashes. The human UniProt source distinguishes experimental supporting papers from inferred statements. ARBA assertions and generated review prose are not used as validating evidence.